Fatty liver is not independently associated with the rates of complete response to oral antiviral therapy in chronic hepatitis B patients

Background & aims Nonalcoholic fatty liver disease (NAFLD) and chronic hepatitis B (CHB) are common liver diseases. Concurrent NAFLD may affect antiviral treatment outcomes in CHB patients. The aim of this study is to investigate the impact of NAFLD on complete viral suppression ([CVS], HBV DNA ...

Full description

Saved in:
Bibliographic Details
Published in:Liver international 2020-05, Vol.40 (5), p.1052-1061
Main Authors: Li, Jie, Le, An K., Chaung, Kevin T., Henry, Linda, Hoang, Joseph K., Cheung, Ramsey, Nguyen, Mindie H.
Format: Article
Language:English
Subjects:
Antiviral agents
antiviral therapy
biochemical responses
Deoxyribonucleic acid
DNA
Fatty liver
HBV
Health care facilities
Hepatitis
Hepatitis B
Hepatitis B e antigen
Histology
Interferon
Liver
Liver diseases
Medical treatment
NAFLD
Patients
Steatosis
Tenofovir
virological responses
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background & aims Nonalcoholic fatty liver disease (NAFLD) and chronic hepatitis B (CHB) are common liver diseases. Concurrent NAFLD may affect antiviral treatment outcomes in CHB patients. The aim of this study is to investigate the impact of NAFLD on complete viral suppression ([CVS], HBV DNA 
ISSN:1478-3223
1478-3231
DOI:10.1111/liv.14415